Updated from 8:21 a.m. to add video.
Alexion Pharmaceuticals (ALXN) - Get Alexion Pharmaceuticals, Inc. Report was upgraded to outperform at BMO Capital. $168 price target. The post-earnings selloff has created a buying opportunity, BMO said.
China Unicom (CHU) - Get China Unicom (Hong Kong) Limited Sponsored ADR Report was downgraded to sell at TheStreet Ratings. You can view the full analysis from the report here: CHU.
Columbia Banking (COLB) - Get Columbia Banking System, Inc. Report was downgraded to neutral from overweight at Piper Jaffray. $31 price target. The company is facing margin pressure and weaker credit quality, Piper said.
Cash America (CSH) was downgraded to market perform from outperform at JMP Securities. The valuation is less attractive, with shares up 37% year to date, JMP said.
World Fuel (INT) - Get World Fuel Services Corporation Report was downgraded to neutral from outperform at Credit Suisse. $45 price target. Earnings estimates were also cut, as the transition process is taking longer, Credit Suisse said.
Molina (MOH) - Get Molina Healthcare, Inc. Report was downgraded to underperform from buy at Bank of America/Merrill Lynch. The company will likely fall short of future guidance given higher medical costs, analysts said.
Synaptics (SYNA) - Get Synaptics Incorporated Report was downgraded to market perform at BMO Capital. $69 price target. Earnings estimates were also cut, as the company lowered guidance again, BMO said.
Western Digital (WDC) - Get Western Digital Corporation Report was downgraded to neutral from outperform at Robert Baird. $50 price target. The company cut guidance, given challenges in the PC market, Robert Baird said.
WEX (WEX) - Get WEX Inc. Report was upgraded to neutral from underweight at JPMorgan. $91 price target. The company is leveraged to higher fuel prices and is seeing better volume growth and credit trends, JPMorgan said.
Whiting Petroleum (WLL) - Get Whiting Petroleum Corporation Report was downgraded to neutral from buy at Sterne Agee. $11 price target. The company's outlook is uncertain heading into 2017, Sterne said.
This article was written by a staff member of TheStreet.